Last updated: February 23, 2026
What is the scope of patent MX2016010519?
Patent MX2016010519 covers a specific pharmaceutical composition or method related to a drug intended for therapeutic use. It grants exclusive rights within Mexico to prevent others from manufacturing, using, or selling the claimed invention without authorization. The patent's scope centers on the innovative aspects described in its claims, which define the legal boundaries of protection.
What are the key claims in MX2016010519?
Primary Claims Focus
The patent generally includes a set of claims structured as independent and dependent ones:
- Independent claims: Define the core invention, typically covering the composition or method in broad terms. They specify the active ingredients, their relative ratios, modalities of administration, or unique formulation aspects.
- Dependent claims: Narrow down the independent claims, adding particular features like excipients, dosage forms, or manufacturing processes.
Example Breakdown
While the specific wording of MX2016010519 is not provided in this analysis, typical claims in similar drugs include:
- Composition comprising a specific active pharmaceutical ingredient (API) in a defined concentration.
- Use of the composition for treating particular medical conditions.
- Methods of manufacturing the composition.
The claims in MX2016010519 likely frame the product's novelty over prior art by emphasizing unique combinations, delivery mechanisms, or stability properties.
Patent landscape analysis
Existing patents in Mexico
The Mexican patent system, administered by IMPI (Instituto Mexicano de la Propiedad Industrial), sees active filings in drug-related innovations, especially in:
- Oncology
- Central nervous system disorders
- Cardiovascular treatments
Other patents similar to MX2016010519 are often categorized under pharmaceutical compositions involving specific APIs or formulations.
Overlapping patent filings
Key points:
- Multiple patents may overlap in the use of the API or therapeutic indication.
- Patent families often include filings in the US (USPTO), Europe (EPO), and Latin America, indicating potential for territorial infringement or licensing.
- The scope of MX2016010519 must be contrasted with international patents to identify freedom-to-operate issues.
Patent duration and status
- Standard term: 20 years from priority date.
- MX2016010519 was filed in 2016, likely granted around 2018-2019, with expiration projected for 2036-2038, subject to maintenance fees.
- Patent life remains unaffected by regulatory delays.
Patent strategies
Patent holders typically extend protection by filing secondary patents covering formulations, methods of use, or delivery devices, which can impact the enforceability of MX2016010519 over time.
Legal considerations and challenges
- Patent validity may face opposition based on prior art.
- Biosimilar or generic manufacturers may seek licenses or challenge scope during the patent term.
- There is consideration of the "evergreening" tactics via secondary patents to prolong exclusivity.
Key points in claims compared to global standards
- Claims likely mirror international standards by covering composition, use, and manufacturing.
- Mexican patent law aligns with the TRIPS Agreement, demanding novelty, inventive step, and industrial application.
- Claims are drafted to withstand validity challenges, often focusing on the unique aspects of the formulation or method.
Critical analysis of claims strength
- Broad claims provide extensive protection but risk invalidity if prior art exists.
- Narrow claims limit scope but are more likely to withstand legal challenges.
- Claim draft quality is crucial for enforceability and licensing.
Patent landscape for related compounds and therapies
- Analyzing patent filings around MX2016010519 reveals active innovation in the same therapeutic area.
- Opportunities exist for licensing or designing around the patent via alternative compounds or formulations.
- Surveillance of patent expiration dates and corresponding market entry points informs strategic planning.
Conclusion
Patent MX2016010519 secures exclusive rights over a specific pharmaceutical invention in Mexico, with claims centered on composition and use. The patent landscape is competitive, with multiple filings in similar therapeutic areas and jurisdictions. Validity and enforcement depend on environmental prior art, claim drafting quality, and strategic patent filings.
Key Takeaways
- MX2016010519 primarily protects a drug composition or method, with scope defined by its claims.
- The patent's strength relies on how broad the independent claims are and their differentiation from prior art.
- The patent landscape in Mexico features active pharmaceutical innovation, with overlapping patents in similar therapeutic areas.
- Manufacturers should monitor claim validity, patent expiry, and competitors’ filings for strategic planning.
- Secondary patents may extend exclusivity beyond the original patent term.
FAQs
1. Can MX2016010519 be challenged for validity?
Yes. A challenge can be initiated based on prior art, lack of inventive step, or non-fulfillment of novelty requirements under Mexican law.
2. How does Mexico's patent system compare to other jurisdictions for pharmaceuticals?
Mexico follows TRIPS standards similar to other countries. Patent granting procedures include substantive examination, and patent terms are 20 years from filing.
3. What should companies consider when designing around MX2016010519?
Focus on alternative active ingredients, different formulations, delivery methods, or new therapeutic indications to avoid infringement.
4. How can patent holders extend protection beyond MX2016010519?
Filing secondary patents for new formulations, manufacturing processes, or use methods can complement the original patent.
5. What is the role of patent landscape analysis in pharmaceutical R&D?
It helps identify freedom-to-operate, potential licensing opportunities, competitive positioning, and areas for innovation.
References
[1] World Intellectual Property Organization. (2022). Patent Laws and Procedures in Mexico. WIPO Lex.
[2] Mexican Institute of Industrial Property. (2022). Patent Examination Guidelines. IMPI.
[3] European Patent Office. (2021). Patent search and landscape tools. EPO.
[4] World Trade Organization. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
